🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Tipranavir high dose

Found 16 matching trials

Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir

PHASE1

To determine the effects of single-dose and steady-state Tipranavir/Ritonav...

Status

Completed

Location

Multiple Locations

Start Date

2003-08

Trial ID

NCT02251769

Treatments Being Tested

Tipranavir Ritonavir Clarithromycin High-Fat Test Meal

Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers

PHASE1

The objective of this study is to establish the tipranavir-ritonavir steady...

Status

Completed

Location

Multiple Locations

Start Date

2000-10

Trial ID

NCT02251132

Treatments Being Tested

TPV low 1 TPV low 2 TPV medium TPV high 1 TPV high 2 RTV low Ritonavir high Radiolabelled erythromycin

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

PHASE1

Study to characterize the effects of two dose combinations of Tipranavir (T...

Status

Terminated

Location

Multiple Locations

Start Date

2002-05

Trial ID

NCT02245438

Treatments Being Tested

Tipranavir low dose Tipranavir high dose Ritonavir low dose Ritonavir high dose Norethindrone-Ethinyl Estradiol

Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers

PHASE1

The objective of this study was to characterize the effect of two dose comb...

Status

Completed

Location

Multiple Locations

Start Date

2001-11

Trial ID

NCT02249416

Treatments Being Tested

Tipranavir (TPV) low Ritonavir (RTV) low Tipranavir (TPV) high Ritonavir (RTV) high Zidovudine

Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

PHASE1

Study to characterise the effects of two dose combinations of tipranavir/ri...

Status

Completed

Location

Multiple Locations

Start Date

2002-05

Trial ID

NCT02251145

Treatments Being Tested

Tipranavir low dose Tipranavir high dose Ritonavir low dose Ritonavir high dose Tenofovir disoproxil fumarate

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

PHASE1

The objective of this study was to characterize the effects of two dose com...

Status

Completed

Location

Multiple Locations

Start Date

2001-12

Trial ID

NCT02253823

Treatments Being Tested

EFV TPV/RTV - low dose TPV/RTV - high dose

Optimizing Treatment for Treatment-Experienced, HIV-Infected People

PHASE3

The goal of anti-HIV therapy is to prevent HIV from replicating. Long-term ...

Status

Completed

Location

Alabama Therapeutics CRS

Start Date

2008-01

Trial ID

NCT00537394

Treatments Being Tested

Enfuvirtide Raltegravir Darunavir Tipranavir Etravirine Maraviroc

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

PHASE2

Objectives of the study were to evaluate the efficacy and safety of two dif...

Status

Terminated

Location

Multiple Locations

Start Date

1999-12

Trial ID

NCT02239835

Treatments Being Tested

Tipranavir (TPV) low dose Tipranavir (TPV) high dose Ritonavir low dose Ritonavir high dose Saquinavir

Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects

PHASE1

Study to determine the relative bioavailability of 500/200 mg of tipranavir...

Status

Completed

Location

Multiple Locations

Start Date

2003-10

Trial ID

NCT02251158

Treatments Being Tested

Tipranavir oral solution Tipranavir capsules Ritonavir oral solution Ritonavir soft gel capsules High fat breakfast

Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

PHASE1

The primary objective of this study is to assess the safety and tolerabilit...

Status

Completed

Location

1182.14.00001 Boehringer Ingelheim Investigational Site

Start Date

2003-11

Trial ID

NCT00076999

Treatments Being Tested

TPV oral solution TPV oral solution RTV oral solution RTV oral solution

Previous Next